CD8A and neoplasm: Significantly higher CD69 levels, in both CD4+ and CD8+ cell populations, were observed in the HPK1 KD group in comparison with WT group (Fig 5A–5B), indicating that HPK1 KD leads to augmentation of T cell activation in the tumor bearing mice.